Journal of Medicinal Chemistry p. 7111 - 7124 (2016)
Update date:2022-08-17
Topics:
Hao, Yongjia
Wang, Xia
Zhang, Tao
Sun, Deheng
Tong, Yi
Xu, Yuqiong
Chen, Haiyang
Tong, Linjiang
Zhu, Lili
Zhao, Zhenjiang
Chen, Zhuo
Ding, Jian
Xie, Hua
Xu, Yufang
Li, Honglin
EGFR-targeted inhibitors (gefitinib and erlotinib) provided an effective strategy for the treatment of non-small-cell lung cancer. However, the EGFR T790M secondary mutation has become a leading cause of clinically acquired resistance to these agents. Her
View MoreJiangxi Huashi Pharmaceutical Co., Ltd
Contact:+86-795-4509628
Address:Ningbo Ave., Fengtian Industrial Park, Fengxin Country, Jiangxi, China.
shanghai jiuling chemical co.,ltd.
Contact:+86-21-50387295
Address:Zaozhuang Road, Pudong, Shanghai City. China
Contact:+86--29-82745382
Address:Development Area Of Lantian Country,Xi'an Shanxi.China
Shanghai united Scientific Co.,Ltd.
Contact:+86-21-53535353
Address:28F No.900 huaihai Road Shanghai China
Anyang Double Circle Auxiliary CO.,LTD
Contact:0086-134 6082 4403
Address:dongfeng road, anyang city, henan province,china
Doi:10.1016/j.tetlet.2007.07.083
(2007)Doi:10.3390/molecules13040831
(2008)Doi:10.1016/j.jct.2004.11.011
(2005)Doi:10.1039/d0ra09202a
(2021)Doi:10.1016/S0040-4039(00)00430-5
(2000)Doi:10.1248/cpb.42.204
(1994)